Several studies have shown that the MMP-1/TIMP(tissue inhibitor of matrix metalloproteinase) ratio is decreased in hypertensive heart disease.

• 多项研究表明发生高血压心脏病时MMP-1/TIMP（金属蛋白酶组织抑制剂）比率降低。